Camostat
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)phenylacetate | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status | ℞ Prescription only |
Routes | Oral |
Identifiers | |
CAS number | 59721-29-8 (mesylate) |
ATC code | B02AB04 |
PubChem | CID 2536 |
ChemSpider | 2440 |
UNII | 0FD207WKDU |
ChEMBL | CHEMBL590799 |
Chemical data | |
Formula | C20H22N4O5 |
Mol. mass | 398.41 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Camostat (INN) is a serine protease inhibitor.
References
- Kunze H, Bohn E (May 1983). "Effects of the serine protease inhibitors FOY and FOY 305 on phospholipase A1 (EC 3.1.1.32) activity in rat - liver lysosomes". Pharmacol Res Commun 15 (5): 451–9. doi:10.1016/S0031-6989(83)80065-4. PMID 6412250.
- Göke B, Stöckmann F, Müller R, Lankisch PG, Creutzfeldt W (1984). "Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion". Digestion 30 (3): 171–8. doi:10.1159/000199102. PMID 6209186.
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.